Results 181 to 190 of about 73,900 (261)
ABSTRACT Aim Kidney excretion of phosphate is the gatekeeper of systemic phosphate homeostasis as evident from inborn and acquired diseases. Renal phosphate transporters are a promising target for phosphate‐lowering drugs, but molecular details of human kidney phosphate handling are largely unknown.
Ashley L. Fernandes +10 more
wiley +1 more source
Clinical manifestations, progression and treatment of post-traumatic hydrocephalus accompanied by contralateral subdural effusion after decompressive craniectomy: a single-center retrospective study. [PDF]
Qiu J, Yan Y, Liu W, Gao G.
europepmc +1 more source
ABSTRACT Transepithelial calcium absorption occurs via a transcellular or paracellular pathway. The intestinal transcellular pathway relies, at least partially, on the apical calcium channel transient receptor potential vanilloid 6 (TRPV6), whereas paracellular calcium (re)absorption occurs through tight junction proteins, including claudin‐2 (CLDN2 ...
Harneet Kaur Bhullar +6 more
wiley +1 more source
Hypercalcaemia After a Sunny Holiday. [PDF]
Ferrie S, Malhotra P, Amal Calist A.
europepmc +1 more source
The G protein–coupled receptor (GPCR) superfamily consists of the most common targets of approved drugs. Targeting GPCRs offers appealing avenues for therapeutic development. Antibodies and their fragments, such as single‐domain antibodies (VHHs or nanobodies), have emerged as useful alternatives to small molecule pharmacophores as building blocks in ...
Shivani Sachdev, Ross W. Cheloha
wiley +1 more source
Effects of Short-term High-dose Vitamin D Supplementation on Mineral Homeostasis in Healthy Young Adults. [PDF]
Králová M +6 more
europepmc +1 more source
Schematic overview of progression from differentiated thyroid carcinoma (DTC) to anaplastic thyroid carcinoma (ATC). ATC primarily develops via two pathways: the BRAF p.V600E‐mutated papillary thyroid carcinoma (PTC) pathway and the RAS‐mutated pathway. The origin and progression of BRAF/RAS‐wildtype ATC remain unclear.
Toru Odate, Tetsuo Kondo
wiley +1 more source

